Artículos por temáticas

[Glucose transporter 1 deficiency syndrome: features of movement disorders, diagnosis and treatment].

Ji XN, Xu CJ, Gao ZJ, Chen SH, Xu KM, Chen Q.

Zhongguo Dang Dai Er Ke Za Zhi. 2018 Mar;20(3):209-213. Chinese.

PET Imaging in Movement Disorders.

Maiti B, Perlmutter JS.

Semin Nucl Med. 2018 Nov;48(6):513-524. doi: 10.1053/j.semnuclmed.2018.07.006. Epub 2018 Aug 16. Review.

Celebrating thirty years of deep brain stimulation in movement disorders patients: A successful marriage between neurologists and neurosurgeons.

Cury RG, Fraix V, Moro E.

Parkinsonism Relat Disord. 2018 Jan;46:98-99. doi: 10.1016/j.parkreldis.2017.11.007. Epub 2017 Nov 11. No abstract available.

Observing movement disorders: best practice proposal in the use of video recording in clinical practice.

Sambati L, Baldelli L, Calandra Buonaura G, Capellari S, Giannini G, Scaglione CLM, Armaroli M, Zoni E, Cortelli P, Martinelli P.

Neurol Sci. 2018 Nov 17. doi: 10.1007/s10072-018-3639-0. [Epub ahead of print]

Movement disorders with neuronal antibodies: syndromic approach, genetic parallels and pathophysiology.

Balint B, Vincent A, Meinck HM, Irani SR, Bhatia KP.

Brain. 2018 Jan 1;141(1):13-36. doi: 10.1093/brain/awx189.

Imaging Transplantation in Movement Disorders.

de Natale ER, Wilson H, Pagano G, Politis M.

Int Rev Neurobiol. 2018;143:213-263. doi: 10.1016/bs.irn.2018.10.002. Epub 2018 Nov 3.

Magnetic Resonance-Guided High Intensity Focused Ultrasound for Treating Movement Disorders.

Kim YG, Kweon EJ, Chang WS, Jung HH, Chang JW.

Prog Neurol Surg. 2018;33:120-134. doi: 10.1159/000481080. Epub 2018 Jan 12.

Botulinum Toxin Treatment of Movement Disorders.

Safarpour Y, Jabbari B.

Curr Treat Options Neurol. 2018 Feb 24;20(2):4. doi: 10.1007/s11940-018-0488-3. Review.

Performance of the Movement Disorders Society criteria for prodromal Parkinson's disease: A population-based 10-year study.

Mahlknecht P, Gasperi A, Djamshidian A, Kiechl S, Stockner H, Willeit P, Willeit J, Rungger G, Poewe W, Seppi K.

Mov Disord. 2018 Feb 13. doi: 10.1002/mds.27281. [Epub ahead of print]

CE: Managing Movement Disorders: A Clinical Review.

Bhimani R, Medina F, Carney-Anderson L.

Am J Nurs. 2018 Dec;118(12):34-40. doi: 10.1097/01.NAJ.0000549666.20957.a3.

Deep brain stimulation for movement disorders.

Krishnan S, Pisharady KK, Divya KP, Shetty K, Kishore A.

Neurol India. 2018 Mar-Apr;66(Supplement):S90-S101. doi: 10.4103/0028-3886.226438. Review.

Acute Psychosis and Movement Disorders as First Presentations of Wilson's Disease.

Raveh Y, Khoury T, Lachish M, Safadi R, Kohn Y.

Isr Med Assoc J. 2018 Dec;20(12):788-789. No abstract available.

Early movement restriction leads to maladaptive plasticity in the sensorimotor cortex and to movement disorders.

Delcour M, Russier M, Castets F, Turle-Lorenzo N, Canu MH, Cayetanot F, Barbe MF, Coq JO.

Sci Rep. 2018 Nov 5;8(1):16328. doi: 10.1038/s41598-018-34312-y.

Abnormal postural behavior in patients with functional movement disorders during exposure to stress.

Zito GA, Apazoglou K, Paraschiv-Ionescu A, Aminian K, Aybek S.

Psychoneuroendocrinology. 2018 Nov 14;101:232-239. doi: 10.1016/j.psyneuen.2018.11.020. [Epub ahead of print]

2018 message from the editor in chief-Movement Disorders journal at cruise speed.

Obeso JA.

Mov Disord. 2018 Jan;33(1):1-2. doi: 10.1002/mds.27289. No abstract available.